影像组学在肝细胞癌经动脉化疗栓塞疗效评估中的应用:系统综述与Meta分析
该系统综述与Meta分析纳入24项研究,评估影像组学预测肝细胞癌经动脉化疗栓塞治疗反应和生存状态的效能。影像组学预测治疗反应和生存状态的总体C-index分别为0.85和0.78,影像组学-临床联合模型表现最佳。
要点
- 影像组学预测TACE治疗反应的总体C-index为0.85,预测生存状态为0.78。
- 影像组学-临床联合模型在训练集和验证集中评估治疗反应的C-index分别为0.93和0.88,生存状态分别为0.84和0.80。
- 联合模型C-index高于影像组学模型和临床模型,影像组学模型又高于临床模型。
核心结论
- 影像组学预测模型对肝细胞癌TACE疗效显示出令人满意的预测性能,影像组学-临床联合预测模型表现最佳。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane Library和Web of Science截至2023年7月12日的文献,最终纳入24项研究,采用影像组学质量评分(RQS)评估纳入文献质量,使用Stata15.0进行Meta分析。
诊断标准与关键数值
- 影像组学预测TACE治疗反应的总体C-index为0.85。
- 影像组学预测TACE生存状态的总体C-index为0.78。
- 联合模型在训练集和验证集中评估治疗反应的C-index分别为0.93和0.88,生存状态分别为0.84和0.80。
- 影像组学模型在训练集和验证集中评估治疗反应的C-index分别为0.87和0.79,生存状态分别为0.79和0.70。
- 临床模型在训练集和验证集中评估治疗反应的C-index分别为0.71和0.66,生存状态分别为0.72和0.66。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
UNLABELLED: RATIONALE AND OBJECTIVES: This meta-analysis was aimed at evaluating the predictive value of radiomics in the context of transarterial chemoembolization (TACE) therapeutic response (TR) for hepatocellular carcinoma (HCC) and patients' survival status (SS) and providing favorable evidence for clinical application.
MATERIALS AND METHODS: We searched for literature in which radiomics was applied to assess the TR of TACE for HCC and the affected patients' survival status across PubMed, Embase, Cochrane Library and Web of Science until Jul 12, 2023. The quality of included literature was evaluated using a radiomics quality score (RQS) approach, and a meta-analysis was conducted using Stata15.0.
RESULTS: Twenty-four studies were included in the analysis. The meta-analysis revealed that the overall concordance-index (C-index) based on radiomics for predicting the TR and SS with TACE was 0.85 and 0.78, respectively. The combined radiomics-clinical model provided the best performance in evaluating the TR and SS associated with TACE. The C-index was 0.93 and 0.88 for TR and 0.84 and 0.80 for SS, in the training and validation sets, respectively. These values were higher than the 0.87 and 0.79 for TR and 0.79 and 0.70 for SS, respectively with the radiomics model, and 0.71 and 0.66 for TR and 0.72 and 0.66 for SS, respectively with the clinical model.
CONCLUSION: The radiomics prediction model for the efficacy of TACE in HCC showed a satisfactory prediction performance. The combined radiomics-clinic prediction model had the best performance.
引用
- Wang Y, Li M, Zhang Z, et al. Application of Radiomics in the Efficacy Evaluation of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Acad Radiol. 2023. PMID: 37684182. doi:10.1016/j.acra.2023.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。